Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma [Phase 1, Phase 2]
Dual CD19/CD22 CAR-T cell therapy is being studied in Phase 1/2 trials for relapsed and refractory Non-Hodgkin lymphoma; the current trial s…
-
CLINICAL_TRIALS research · 2018-03-19Clinical Trial Update: Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016
This clinical trial update reports a unicentric retrospective analysis of 602 young adult and adolescent patients (ages 15-30) with hematolo…
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This clinical trial update discusses an ongoing Phase 1/2 study of TQB2303 for aggressive CD20-positive Non-Hodgkin lymphoma, with the curre…
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) [Phase 1, Phase 2]
Phase 1/2 study investigating Antiminor Histocompatibility Complex (MiHA) T cells in patients with relapsed hematologic malignancies after m…
-
CLINICAL_TRIALS research · 2017-11-24Clinical Trial Update: Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
An Italian multicenter retrospective observational study on transformed non-Hodgkin lymphoma, with the study status currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 [Phase 1]
Phase 1 pharmacokinetic study to assess how ketoconazole affects the metabolism of venetoclax (ABT-199) in patients with Non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2017-10-24Clinical Trial Update: Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluates the combination of Rituximab with autologous effector lymphocytes in follicular lymphoma patients respond…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of CT-1530 in relapsed or refractory B-cell non-Hodgkin lymphoma, chronic lymphocyt…
-
CLINICAL_TRIALS research · 2017-07-07Clinical Trial Update: Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS [NA]
Completed clinical trial evaluating minimal residual disease in diffuse large B-cell lymphoma using cell-free circulating DNA detected by ne…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 study assessing sequential infusion of CD19- and CD20-directed CAR-T cells in relapsed or refractory B-cell lymphoma.
-
CLINICAL_TRIALS research · 2017-06-26Clinical Trial Update: Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma [Phase 1]
Phase 1 pharmacokinetics and pharmacodynamics study of GSK461364 in subjects with Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2017-06-26Clinical Trial Update: Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL)
An ongoing observational study in the Czech Republic examining the epidemiology and clinical aspects of Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study of an anti-CD19 CAR-T cell therapy for refractory/relapsed B-cell malignancies…
-
CLINICAL_TRIALS research · 2017-03-31Clinical Trial Update: The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas
This clinical trial explores whether monocyte subpopulations can predict prognosis in lymphomas, including diffuse large B-cell lymphoma. It…
-
CLINICAL_TRIALS research · 2017-03-09Clinical Trial Update: Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Administrative update reporting procurement of follicular B cell lymphoma cells for potential use in future clinical trials.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation [NA]
Pilot study evaluating whether hyperbaric oxygen therapy can improve outcomes during autologous peripheral blood stem cell transplantation i…
-
CLINICAL_TRIALS research · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy [Phase 4]
Phase 4 clinical trial investigates prophylactic entecavir to prevent hepatitis B reactivation in HBsAg-positive lymphoma patients treated w…
-
CLINICAL_TRIALS research · 2016-12-21Clinical Trial Update: To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma [Phase 4]
This clinical trial update notes a Phase 4 study comparing the duration of prophylactic Tenofovir use in patients with Non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS research · 2016-12-19Clinical Trial Update: PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia [Phase 4]
Phase 4 clinical trial evaluating PEG-rhG-CSF (pegfilgrastim) to prevent chemotherapy-induced neutropenia in patients with Non-Hodgkin lymph…
-
CLINICAL_TRIALS research · 2016-11-09Clinical Trial Update: Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients [NA]
This clinical trial update examines the incidence of hepatitis B reactivation in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies [Phase 2]
A Phase 2 clinical trial update evaluating sequential CAR-T cell therapy followed by hematopoietic stem cell transplantation for relapse/ref…
-
CLINICAL_TRIALS research · 2016-08-22Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Infusion [Phase 1, Phase 2]
Clinical trial update on a liposomal mitoxantrone formulation being studied in Non-Hodgkin lymphoma in Phase 1/Phase 2; current status is un…
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
This is a completed observational study conducted in Latin America evaluating participants with chronic lymphocytic leukemia, multiple myelo…
-
CLINICAL_TRIALS research · 2016-07-19Clinical Trial Update: BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a BEB conditioning regimen for autologous stem-cell transplantation in non-Hodgkin lymphoma, with the cu…